115 filings
Page 5 of 6
8-K
wpyy8wu
13 May 21
Silverback Therapeutics Reports First Quarter 2021 Financial Results
4:17pm
DEFA14A
pm3vvvhkejs1n
22 Apr 21
Additional proxy soliciting materials
4:02pm
DEF 14A
7g2rpq2x
22 Apr 21
Definitive proxy
4:01pm
S-8
32okb
29 Mar 21
Registration of securities for employees
4:27pm
10-K
dzl106u ot1am4ryp6
29 Mar 21
Annual report
4:13pm
8-K
3xlnt lnif1x1tte8y
29 Mar 21
Silverback Therapeutics Reports Fourth Quarter and Full Year 2020
4:11pm
8-K
kaxs7w
15 Mar 21
Silverback Therapeutics Announces the Appointment of Dr. Maria Koehler to its Board of Directors
4:05pm
8-K
uswi 6ta56mrq6w
8 Dec 20
Silverback Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
5:25pm
S-8
5f9pj3fwa
4 Dec 20
Registration of securities for employees
4:15pm
424B4
obg7b
4 Dec 20
Prospectus supplement with pricing info
4:04pm
EFFECT
km0a24o3g0ooj
4 Dec 20
Notice of effectiveness
12:15am
S-1MEF
2ws6fbu
3 Dec 20
Registration of additional securities for an S-1
9:40pm
CERT
qb6j hxnh
3 Dec 20
Certification of approval for exchange listing
10:24am
SEC STAFF
1qjked
3 Dec 20
SEC staff action: Order
12:00am
8-A12B
fijf4o
1 Dec 20
Registration of securities on exchange
4:31pm
CORRESP
pyee8h65
1 Dec 20
Correspondence with SEC
12:00am
CORRESP
b2iihnu8rxkc9gzk3dj
1 Dec 20
Correspondence with SEC
12:00am
S-1/A
8p0 q5plqvr6c
30 Nov 20
IPO registration (amended)
6:06am
CORRESP
hh3n30nlngu
30 Nov 20
Correspondence with SEC
12:00am